General


Peptide: 1002 or L1002
Microorganism:Klebsiella pneumoniae LM21
Administration:
Stage: Formation (3-24h)
Notes:In a Bioflux Microfluidics System

Experimental procedure


Method AMP Effect(Biofilm reduction) Concentration Notes
Confocal microscopy-fluorescence Not Active 6.053 uM

Reference



M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.

Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com